SE511313C2 - Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol - Google Patents

Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol

Info

Publication number
SE511313C2
SE511313C2 SE9700061A SE9700061A SE511313C2 SE 511313 C2 SE511313 C2 SE 511313C2 SE 9700061 A SE9700061 A SE 9700061A SE 9700061 A SE9700061 A SE 9700061A SE 511313 C2 SE511313 C2 SE 511313C2
Authority
SE
Sweden
Prior art keywords
composition
composition according
weight
diglycerol
phase
Prior art date
Application number
SE9700061A
Other languages
English (en)
Swedish (sv)
Other versions
SE9700061D0 (sv
SE9700061L (sv
Inventor
Kaare Larsson
Helena Ljusberg-Wahren
Niels Krog
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Priority to SE9700061A priority Critical patent/SE511313C2/sv
Publication of SE9700061D0 publication Critical patent/SE9700061D0/xx
Priority to US09/341,294 priority patent/US6660278B1/en
Priority to PCT/SE1998/000009 priority patent/WO1998030206A1/en
Priority to AT98900793T priority patent/ATE243024T1/de
Priority to CA002277377A priority patent/CA2277377C/en
Priority to DE69815659T priority patent/DE69815659T2/de
Priority to EP98900793A priority patent/EP0954287B1/en
Priority to JP53080298A priority patent/JP2001508773A/ja
Priority to AU55832/98A priority patent/AU5583298A/en
Publication of SE9700061L publication Critical patent/SE9700061L/xx
Publication of SE511313C2 publication Critical patent/SE511313C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9700061A 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol SE511313C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
AU55832/98A AU5583298A (en) 1997-01-13 1998-01-08 Controlled release composition
CA002277377A CA2277377C (en) 1997-01-13 1998-01-08 Controlled release composition
PCT/SE1998/000009 WO1998030206A1 (en) 1997-01-13 1998-01-08 Controlled release composition
AT98900793T ATE243024T1 (de) 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung
US09/341,294 US6660278B1 (en) 1997-01-13 1998-01-08 Controlled release composition
DE69815659T DE69815659T2 (de) 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung
EP98900793A EP0954287B1 (en) 1997-01-13 1998-01-08 Controlled release composition
JP53080298A JP2001508773A (ja) 1997-01-13 1998-01-08 徐放性組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol

Publications (3)

Publication Number Publication Date
SE9700061D0 SE9700061D0 (sv) 1997-01-13
SE9700061L SE9700061L (sv) 1998-07-14
SE511313C2 true SE511313C2 (sv) 1999-09-06

Family

ID=20405393

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol

Country Status (9)

Country Link
US (1) US6660278B1 (enExample)
EP (1) EP0954287B1 (enExample)
JP (1) JP2001508773A (enExample)
AT (1) ATE243024T1 (enExample)
AU (1) AU5583298A (enExample)
CA (1) CA2277377C (enExample)
DE (1) DE69815659T2 (enExample)
SE (1) SE511313C2 (enExample)
WO (1) WO1998030206A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
PL211116B1 (pl) * 2001-10-19 2012-04-30 Idexx Lab Komozycja do podawania ssakowi związku farmakologicznie czynnego i sposób wytwarzania preparatu do wstrzyknięć
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
PL1768650T3 (pl) 2004-06-04 2009-01-30 Camurus Ab Ciekłe formulacje depot
US9801913B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Barrier layer
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
WO2006036982A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Drug delivery coating for use with a stent
US9592324B2 (en) 2006-11-06 2017-03-14 Atrium Medical Corporation Tissue separating device with reinforced support for anchoring mechanisms
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
EP1933991A4 (en) 2005-10-15 2012-05-02 Atrium Medical Corp HYDROPHOBIC NETWORKED GEL FOR BIOABSORBIBLE MEDICINAL CARRIER COVERS
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
EP2393472B1 (en) 2008-12-05 2019-06-05 NanoMed Holdings Pty Ltd Amphiphile prodrugs
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011050388A1 (en) * 2009-10-30 2011-05-05 Monash University Liquid crystal composition and method of use
WO2011145659A1 (ja) * 2010-05-18 2011-11-24 富士フイルム株式会社 カロチノイド含有組成物及びその製造方法
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
AU2013294915C1 (en) 2012-07-26 2019-11-21 Camurus Ab Opioid formulations
ES2837803T3 (es) 2012-07-26 2021-07-01 Camurus Ab Formulaciones de opioides
UA128186C2 (uk) 2017-11-27 2024-05-01 Умекрайн Когнішн Аб ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ 3<font face="Symbol">a</font>-ЕТИНІЛ-3<font face="Symbol">b</font>-ГІДРОКСІАНДРОСТАН-17-ОНУ ОКСИМУ
WO2019204869A1 (en) 2018-04-26 2019-10-31 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs
EP3810622A4 (en) 2018-06-21 2022-04-06 NanoMed Holdings Pty Ltd PLATINUM BASED AMPHIPHILIC PRODRUGS
CN116867376B (zh) * 2021-01-29 2026-06-05 Ioi油脂化学品有限责任公司 含有聚甘油脂肪酸酯的组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (enExample) * 1974-10-19 1978-07-03
US5264460A (en) * 1988-05-30 1993-11-23 Deutsche Solvay-Werke Gmbh Process for preparing nonionic surfactants
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
IE65045B1 (en) 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US6013269A (en) * 1994-10-12 2000-01-11 The Procter & Gamble Company Cosmetic make-up compositions
SE504582C2 (sv) 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
US6660278B1 (en) 2003-12-09
JP2001508773A (ja) 2001-07-03
CA2277377A1 (en) 1998-07-16
SE9700061D0 (sv) 1997-01-13
SE9700061L (sv) 1998-07-14
EP0954287B1 (en) 2003-06-18
WO1998030206A1 (en) 1998-07-16
ATE243024T1 (de) 2003-07-15
AU5583298A (en) 1998-08-03
DE69815659D1 (de) 2003-07-24
EP0954287A1 (en) 1999-11-10
CA2277377C (en) 2007-12-18
DE69815659T2 (de) 2004-04-29

Similar Documents

Publication Publication Date Title
EP0954287B1 (en) Controlled release composition
CA2182577C (en) Lipophilic carrier preparations
CA2232541C (en) Fractionated vegetable oil
Constantinides Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects
FI97687B (fi) Säännöstellysti vapauttava koostumus L2-faasiin liuotettua tai dispergoitua biologisesti aktiivista ainetta varten
MXPA01009817A (es) Composiciones farmaceuticas orales las cuales contienen trigliceridos de cadena larga y tensioactivos lipofilicos.
JPH09508413A (ja) 水中油エマルジョン
US20030211140A1 (en) Oil-core compositions for the sustained release of hydrophobic drugs
Norn Polyglycerol esters
US10080803B2 (en) Emulsified krill phospholipid compositions
EP0084341B1 (en) Emulsion-type composition for external use
JP6148416B2 (ja) コアシェル構造体及び外用剤
US6235312B1 (en) Liquid crystalline phase drug delivery vehicle
EP1670436B1 (en) Composition comprising ether lipid
US20040213837A1 (en) Oil-core compositions for the sustained release of hydrophobic drugs
RU2127124C1 (ru) Препараты липофильных носителей
JP2016117681A (ja) コアシェル構造体を含有する製剤
JP7712737B1 (ja) オキサゾール化合物含有組成物
JPH01174355A (ja) 経皮、経粘膜による物質の吸収を促進する組成物
BRPI0720489A2 (pt) Cápsulas de gelatina compreendendo um ácido
WO2016076786A1 (en) Mucoadhesive emollient

Legal Events

Date Code Title Description
NUG Patent has lapsed